424 related articles for article (PubMed ID: 9823337)
1. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
[TBL] [Abstract][Full Text] [Related]
2. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
[TBL] [Abstract][Full Text] [Related]
3. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.
Singh AV; Franke AA; Blackburn GL; Zhou JR
Cancer Res; 2006 Feb; 66(3):1851-8. PubMed ID: 16452247
[TBL] [Abstract][Full Text] [Related]
4. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer.
Su SJ; Yeh TM; Lei HY; Chow NH
Clin Cancer Res; 2000 Jan; 6(1):230-6. PubMed ID: 10656454
[TBL] [Abstract][Full Text] [Related]
5. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity.
Su SJ; Chow NH; Kung ML; Hung TC; Chang KL
Nutr Cancer; 2003; 45(1):113-23. PubMed ID: 12791511
[TBL] [Abstract][Full Text] [Related]
6. Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors.
Yang X; Belosay A; Hartman JA; Song H; Zhang Y; Wang W; Doerge DR; Helferich WG
Clin Exp Metastasis; 2015 Apr; 32(4):323-33. PubMed ID: 25749878
[TBL] [Abstract][Full Text] [Related]
7. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice.
Zhou JR; Yu L; Mai Z; Blackburn GL
Int J Cancer; 2004 Jan; 108(1):8-14. PubMed ID: 14618609
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
[TBL] [Abstract][Full Text] [Related]
9. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells.
Pagliacci MC; Smacchia M; Migliorati G; Grignani F; Riccardi C; Nicoletti I
Eur J Cancer; 1994; 30A(11):1675-82. PubMed ID: 7833143
[TBL] [Abstract][Full Text] [Related]
10. Soy processing influences growth of estrogen-dependent breast cancer tumors.
Allred CD; Allred KF; Ju YH; Goeppinger TS; Doerge DR; Helferich WG
Carcinogenesis; 2004 Sep; 25(9):1649-57. PubMed ID: 15131010
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones.
Bielecki A; Roberts J; Mehta R; Raju J
Nutr Cancer; 2011; 63(1):139-50. PubMed ID: 21161820
[TBL] [Abstract][Full Text] [Related]
12. Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer.
Mizunuma H; Kanazawa K; Ogura S; Otsuka S; Nagai H
Oncology; 2002; 62(1):78-84. PubMed ID: 11810047
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones and cancer prevention.
Sarkar FH; Li Y
Cancer Invest; 2003; 21(5):744-57. PubMed ID: 14628433
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats.
Constantinou AI; Lantvit D; Hawthorne M; Xu X; van Breemen RB; Pezzuto JM
Nutr Cancer; 2001; 41(1-2):75-81. PubMed ID: 12094632
[TBL] [Abstract][Full Text] [Related]
15. Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice.
Santell RC; Kieu N; Helferich WG
J Nutr; 2000 Jul; 130(7):1665-9. PubMed ID: 10867033
[TBL] [Abstract][Full Text] [Related]
16. Different mechanisms of soy isoflavones in cell cycle regulation and inhibition of invasion.
Kim MH; Gutierrez AM; Goldfarb RH
Anticancer Res; 2002; 22(6C):3811-7. PubMed ID: 12552999
[TBL] [Abstract][Full Text] [Related]
17. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
19. Preliminary studies on induction of apoptosis by genistein on HepG2 cell line.
Chodon D; Ramamurty N; Sakthisekaran D
Toxicol In Vitro; 2007 Aug; 21(5):887-91. PubMed ID: 17391909
[TBL] [Abstract][Full Text] [Related]
20. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
